Wordsworth, P., Dijkmans, B., van der Heijde, D., Davis, J., Schiff, M., Kivitz, A., Sieper, J., Mease, P., Kupper, H., Wong, R., & Grp, A. (2016). Adalimumab sustains improvement in spinal mobility in as patients through 104 weeks - Results from atlas. 47, II78–II79.

Wordsworth, P., et al. Adalimumab Sustains Improvement in Spinal Mobility in as Patients through 104 Weeks - Results from Atlas. 2016, pp. II78–II79.

Wordsworth, P, B Dijkmans, D van der Heijde, J Davis, M Schiff, A Kivitz, J Sieper, et al. 2016. “Adalimumab Sustains Improvement in Spinal Mobility in as Patients through 104 Weeks - Results from Atlas.” In , 47:II78–II79.